Stay updated on MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.

Latest updates to the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision changed from v3.3.1 to v3.3.2 on the page, a minor system update that does not affect study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the study page; this appears to be a metadata/version update and does not alter study details, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedThe funding-related notice at the top of the page has been removed. This was a generic site-wide alert and does not change the study details or eligibility information presented on the page.SummaryDifference0.3%

- Check43 days agoChange DetectedThe Study Details page appears unchanged between the two screenshots; no major sections or data were added or removed. The information about MEDI4736, Tremelimumab, azacitidine, eligibility, and locations remains as shown.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference4%

- Check79 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.